Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Aardvark Therapeutics Inc (NASDAQ: AARD) closed the day trading at $9.67 up 3.20% from the previous closing price of $9.37. In other words, the price has increased by $3.20 from its previous closing price. On the day, 0.17 million shares were traded. AARD stock price reached its highest trading level at $9.705 during the session, while it also had its lowest trading level at $9.2838.
Ratios:
For a better understanding of AARD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.03 and its Current Ratio is at 12.03. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on November 07, 2025, initiated with a Buy rating and assigned the stock a target price of $26.
On September 29, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $24.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $40.H.C. Wainwright initiated its Buy rating on June 30, 2025, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 15 ’25 when Lee Tien-Li bought 10,000 shares for $9.66 per share. The transaction valued at 96,624 led to the insider holds 1,543,384 shares of the business.
VICKERS VENT GLB DEEP-TECH FND bought 10,360 shares of AARD for $93,413 on Sep 15 ’25. On Sep 10 ’25, another insider, Lee Tien-Li, who serves as the Chief Executive Officer of the company, bought 9,000 shares for $7.91 each. As a result, the insider paid 71,212 and bolstered with 1,522,384 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AARD now has a Market Capitalization of 210547536 and an Enterprise Value of 84742544.
Stock Price History:
Over the past 52 weeks, AARD has reached a high of $19.58, while it has fallen to a 52-week low of $4.88. The 50-Day Moving Average of the stock is -20.05%, while the 200-Day Moving Average is calculated to be -13.12%.
Shares Statistics:
Over the past 3-months, AARD traded about 182.75K shares per day on average, while over the past 10 days, AARD traded about 148970 shares per day. A total of 21.75M shares are outstanding, with a floating share count of 12.48M. Insiders hold about 42.68% of the company’s shares, while institutions hold 25.48% stake in the company. Shares short for AARD as of 1763078400 were 1099118 with a Short Ratio of 6.01, compared to 1760486400 on 559841. Therefore, it implies a Short% of Shares Outstanding of 1099118 and a Short% of Float of 7.739999999999999.
Earnings Estimates
Aardvark Therapeutics Inc (AARD) is currently under the scrutiny of 4 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.83 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$2.89 and -$3.0 for the fiscal current year, implying an average EPS of -$2.94. EPS for the following year is -$3.47, with 6.0 analysts recommending between -$1.99 and -$5.92.
